World's Best Scientists 2026 revealed!
Renato D. Lopes

Renato D. Lopes

D-Index & Metrics

Medicine

D-Index
109
Citations
59268
World Ranking
5677
National Ranking
3057

Renato D. Lopes publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Renato D. Lopes sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 823 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Renato D. Lopes D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Renato D. Lopes sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 109 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Renato D. Lopes is affiliated with Duke University in the United States. Their research primarily focuses on Medicine, with a particular emphasis on Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism, Infectious Diseases, and Internal Medicine. Their extensive publication record encompasses a broad range of topics related to these fields.

The main topics covered in Renato D. Lopes's work include:

  • Atrial Fibrillation Management and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Arrhythmias and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • COVID-19 Clinical Research Studies
  • Diabetes Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life

Their frequent co-authors include:

  • John H. Alexander
  • Christopher B. Granger
  • Shaun G. Goodman
  • Roxana Mehran
  • Philippe Gabríel Steg

Renato D. Lopes has published extensively in well-established journals, with frequent contributions to:

  • Journal of the American College of Cardiology
  • Circulation
  • American Heart Journal
  • European Heart Journal
  • JAMA Cardiology

Selected recent papers authored or co-authored by Renato D. Lopes illustrate the scope and impact of their research:

  • "Initial Invasive or Conservative Strategy for Stable Coronary Disease," 2020, published in New England Journal of Medicine
  • "Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure," 2020, published in New England Journal of Medicine
  • "Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials," 2021, published in The Lancet Diabetes & Endocrinology
  • "Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19," 2020, published in JAMA
  • "Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19," 2020, published in New England Journal of Medicine

Best Publications

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

  • Initial invasive or conservative strategy for stable coronary disease.

    David J. Maron;Judith S. Hochman;Harmony R. Reynolds;Sripal Bangalore

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    Deepak L. Bhatt;Michael Szarek;P. Gabriel Steg;Christopher P. Cannon

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.

    Bruno M Tomazini;Israel S Maia;Alexandre B Cavalcanti;Otavio Berwanger

  • Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.

    Alexandre B. Cavalcanti;Fernando G. Zampieri;Regis G. Rosa;Luciano C.P. Azevedo

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

    R.D. Lopes;G. Heizer;R. Aronson;A.N. Vora

  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

    Deepak L. Bhatt;Michael Szarek;Bertram Pitt;Christopher P. Cannon

  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

    Naveed Sattar;Matthew M Y Lee;Søren L Kristensen;Kelley R H Branch

  • Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.

    Stefan H. Hohnloser;Ziad Hijazi;Laine Thomas;John H. Alexander

  • Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

    Renato D. Lopes;John H. Alexander;Sana M. Al-Khatib;Jack Ansell

  • The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

    Ziad Hijazi;Jonas Oldgren;Johan Lindbäck;John H Alexander

  • Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.

    Renato D Lopes;Pedro Gabriel Melo de Barros e Silva;Remo H M Furtado;Ariane Vieira Scarlatelli Macedo

  • Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.

    Sigrun Halvorsen;Dan Atar;Dan Atar;Hongqiu Yang;Raffaele De Caterina

  • The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

    Ziad Hijazi;Johan Lindbäck;John H. Alexander;Michael Hanna

  • Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes

    Elaine M. Hylek;Claes Held;John H. Alexander;Renato D. Lopes

  • Endoscopic versus Open Vein-Graft Harvesting in Coronary-Artery Bypass Surgery

    Renato D. Lopes;Gail E. Hafley;Keith B. Allen;T. Bruce Ferguson

Frequent Co-Authors

John H. Alexander
John H. Alexander Duke University
Christopher B. Granger
Christopher B. Granger Duke University
Lars Wallentin
Lars Wallentin Uppsala University
Elaine M. Hylek
Elaine M. Hylek Boston University
Michael G. Hanna
Michael G. Hanna University College London
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Sana M. Al-Khatib
Sana M. Al-Khatib Duke University
Eric D. Peterson
Eric D. Peterson The University of Texas Southwestern Medical Center
Robert A. Harrington
Robert A. Harrington Cornell University
Paul W. Armstrong
Paul W. Armstrong University of Alberta

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens a variety of related online degrees and certification pathways. For those interested in advancing clinical expertise, cheapest online dnp programs provide a cost-effective route to earn a Doctor of Nursing Practice degree. These programs can help nurses move into leadership or specialized clinical roles.

Pharmacy is another rewarding field. Prospective pharmacists can take advantage of the best online pharmacy school options, which combine flexibility with high academic standards. These programs are ideal for students juggling work or other commitments.

Not all healthcare careers require direct patient care. For example, online schools for health information management equip students with the skills to organize and secure medical data, a vital area in today’s digital healthcare landscape.

Entry-level specialties such as medical coding also offer accessible starting points. Understanding medical billing and coding certification cost can help plan your education and launch your healthcare career in as little as a year.

Best Scientists Citing Renato D. Lopes

Trending Scientists

Recently Published Articles